| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/2003 | US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/01/2003 | US6586452 C1 to C4 side chain modified nodulisporic acid analogs |
| 07/01/2003 | US6586450 E.g., (2-(4-methoxyphenethyl))-N'-(2-(5-bromopyridyl))-thiourea; enzyme inhibitors of reverse transcriptase; viricides for HIV infection, including mutant, drug-sensitive, drug and multi-drug resistance strains |
| 07/01/2003 | US6586449 Nicotine-containing, controlled release composition and method |
| 07/01/2003 | US6586448 Cholesteryl ester transfer protein inhibitors used as antilipemic agents for prophylaxis of cardiovascular disorders |
| 07/01/2003 | US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies |
| 07/01/2003 | US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea |
| 07/01/2003 | US6586444 Medicinal compositions |
| 07/01/2003 | US6586443 Administering opiate receptor antagonists such as naltrexone or naloxone for prophylaxis of autoimmune and viral diseases |
| 07/01/2003 | US6586442 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/01/2003 | US6586441 Adenosine receptor ligands and their use in the treatment of disease |
| 07/01/2003 | US6586440 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme |
| 07/01/2003 | US6586439 Pharmaceutically active compounds |
| 07/01/2003 | US6586438 Low dose combination of metformin and another antidiabetic agent such as glyburide; side effect reduction; for first line therapy in treating diabetes |
| 07/01/2003 | US6586437 (S)-hydroxynefazodone antipsychotic therapy |
| 07/01/2003 | US6586436 Serotonergic agents |
| 07/01/2003 | US6586434 Method for the preparation of tetrahydrobenzothiepines |
| 07/01/2003 | US6586432 Neurokinin-1 receptor antagonists |
| 07/01/2003 | US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/01/2003 | US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders |
| 07/01/2003 | US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 07/01/2003 | US6586428 Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 07/01/2003 | US6586427 Treatments for nervous disorders |
| 07/01/2003 | US6586426 Pyrrolizine derivatives; thrombin, elastase, and factor X inhibitors |
| 07/01/2003 | US6586425 Administering a non-corneotoxic ophthalmic preparation which affects the actin filaments of the eye; macrolides such as latrunculin-A, latrunculin-B, swinholide-A, and jasplakinolide |
| 07/01/2003 | US6586424 Anticancer agents; anticholesterol agents |
| 07/01/2003 | US6586423 Tyrosine kinase inhibitors |
| 07/01/2003 | US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 07/01/2003 | US6586421 For therapy of central nervous system, including diseases, disorders, and conditions related to, such as anxiety, depression, hypertension, migraine, obesity, compulsive disorders, schizophrenia, autism, neurodegenerative disorders |
| 07/01/2003 | US6586419 Phototherapeutic inactivation of ocular viruses |
| 07/01/2003 | US6586417 Enhancing physical performance |
| 07/01/2003 | US6586416 Hypotensive agents for those suffering from aldosteronism; canrenone, spironolactone and amiloride |
| 07/01/2003 | US6586414 Treatment of cerebrovascular disease |
| 07/01/2003 | US6586413 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists |
| 07/01/2003 | US6586407 Injectable pharmaceutical formulations for partricin derivatives |
| 07/01/2003 | US6586406 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 07/01/2003 | US6586404 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/01/2003 | US6586402 Leucine replaced by neopentylglycine or adamantylalanine |
| 07/01/2003 | US6586391 Method of ameliorating erectile dysfunction |
| 07/01/2003 | US6586242 TAO protein kinases and methods of use therefor |
| 07/01/2003 | US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a |
| 07/01/2003 | US6586020 Bradykinin antagonists comprising rosaceae plant extracts |
| 07/01/2003 | US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes |
| 07/01/2003 | US6586012 To mask the unpleasant taste of pharmaceuticals or nutritional supplements |
| 07/01/2003 | US6586005 Extended release formulation of etodolac |
| 07/01/2003 | US6586004 Drug such as lansoprazole, voglibose, or candesartan cilexetil, water soluble sugar alcohol, and low-substituted hydroxypropyl cellulose; tablet with improved buccal disintegration or dissolution |
| 07/01/2003 | US6586003 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/01/2003 | US6586000 Hydroxide-releasing agents as skin permeation enhancers |
| 07/01/2003 | US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 07/01/2003 | US6585996 Preferably tetrahydrofurfuryl disulfide; administration methods may include suppository forms, transdermal carriers, such as gels, lotions, or creams; and oral carriers, such as tablets or capsules |
| 07/01/2003 | US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level |
| 07/01/2003 | US6585993 Controlled release neurotoxin system |
| 07/01/2003 | US6585988 Controlling the regulatory mechanism that governs cell division in a damaged cell structure which reactivated the proliferative phase regulated by DNA to enable the damaged cell to redifferentiate itself by genetic code |
| 07/01/2003 | US6585982 Treatment of infertility |
| 07/01/2003 | US6585974 Preventives for hepatopathy |
| 07/01/2003 | US6585967 Adhesive treatment for tinea cruris |
| 07/01/2003 | US6585963 Nail compositions and methods of administering same |
| 07/01/2003 | US6585961 Antimicrobial compositions |
| 07/01/2003 | US6585959 Excipient having different particle size distribution are added in alternate layers into a suitable mixing vessel; mixing together using a suitable mixer, wherein a portion of the excipient having the larger particle size is added first |
| 07/01/2003 | US6585958 Medicinal aerosol formulations |
| 07/01/2003 | CA2270088C Estrogen- and progesterone-based pharmaceutical composition |
| 07/01/2003 | CA2256227C Method of treating psychiatric conditions |
| 07/01/2003 | CA2166243C Apoptosis-modulating composition containing a factor modifying intracellular methional and malondialdehyde rates |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/26/2003 | WO2003052414A1 Screening method |
| 06/26/2003 | WO2003052106A1 Method of screening compounds |
| 06/26/2003 | WO2003052095A2 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 06/26/2003 | WO2003052058A2 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 06/26/2003 | WO2003052052A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 06/26/2003 | WO2003051979A2 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 06/26/2003 | WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 06/26/2003 | WO2003051900A1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
| 06/26/2003 | WO2003051893A2 Improvements in pharmaceutical compositions |
| 06/26/2003 | WO2003051890A1 Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides |
| 06/26/2003 | WO2003051889A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| 06/26/2003 | WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 06/26/2003 | WO2003051887A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 06/26/2003 | WO2003051886A1 Pyrazolopyridazine derivatives |
| 06/26/2003 | WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof |
| 06/26/2003 | WO2003051884A1 Fused indole compound, process for producing the same, and use |
| 06/26/2003 | WO2003051883A1 Indole derivative |
| 06/26/2003 | WO2003051880A1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
| 06/26/2003 | WO2003051874A1 Bicyclic n-arylamides |
| 06/26/2003 | WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 06/26/2003 | WO2003051870A1 Novel compounds |
| 06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 06/26/2003 | WO2003051868A1 Lactams as tachykinin antagonists |
| 06/26/2003 | WO2003051867A1 New process |
| 06/26/2003 | WO2003051864A1 Isoflavonoid conjugates, compositions thereof and therapeutic methods involving same |
| 06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
| 06/26/2003 | WO2003051859A1 Compounds for imaging alzheimer's disease |
| 06/26/2003 | WO2003051858A1 Method of obtaining 2-(2-nitrovinyl)-furan and the use thereof as a coccidiostatic |
| 06/26/2003 | WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 06/26/2003 | WO2003051854A1 Thiadiazoline derivative |
| 06/26/2003 | WO2003051851A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 06/26/2003 | WO2003051845A1 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
| 06/26/2003 | WO2003051844A1 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |